A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.

NCT02174211 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: Ranibizumab
DRUG: Aflibercept

Sponsor

King's College Hospital NHS Trust

Collaborators

[object Object]